Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1841
Supernus Pharmaceuticals, Inc. - Common Stock
43.7
3
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.04%
Monthly Change
-5.55%
6 month change
-19.00%
Year Change
-19.02%
Previous Close
44.1
9
Open
43.7
3
Low
43.7
3
High
43.7
3
Volume
115
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
SUPN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
52.92 M
53.39 M
54.38 M
54.73 M
55.81 M
57.58 M
58.13 M
Valuation ratios
Enterprise value
1.41 B
1.73 B
2.35 B
1.44 B
1.95 B
2.73 B
2.37 B
Price to earnings ratio
10.66
29.76
36.03
1 386.5
27.39
-73.09
-22.86
Price to sales ratio
2.6
2.73
3.46
2.53
3.06
3.9
3.02
Price to cash flow ratio
9.76
12.47
19.78
13.86
11.77
59.28
131.97
Price to book ratio
1.81
1.94
2.61
1.67
1.95
2.64
0.59
Enterprise value to EBITDA ratio
7.34
14.61
17.82
18.13
12.02
93.35
-82.45
Profitability ratios
Return on assets %
0.08
0.03
0.04
0
0.05
-0.03
-0.04
Return on equity %
0.17
0.07
0.07
0
0.07
-0.04
-0.06
Return on invested capital %
56.82
21.61
12.96
0.78
22.24
-16.1
-19.94
Gross margin %
89.92
87.05
86.93
86.21
88.23
89.63
84.63
Operating margin %
33.38
14.84
6.91
0.87
12.34
-8.66
-26.46
EBITDA margin %
36.86
20.46
19.73
13.1
24.49
4.07
-14.71
Net margin %
24.39
9.21
9.1
0.22
11.16
-5.36
-26.65
Liquidity ratios
Quick ratio
2.37
1.63
0.93
1.43
2.16
1.57
1.77
Current ratio
2.57
1.91
1.07
1.7
2.35
1.9
2.08
Inventory turnover
1.4
1.12
0.98
0.99
1.18
0.66
0.31
Asset turnover
0.39
0.36
0.39
0.41
0.5
0.49
0.15
Solvency ratios
Debt to assets ratio
0.24
0.22
0.24
—
—
—
—
Debt to equity ratio
0.49
0.46
0.45
—
—
—
—
Long term debt to total assets ratio
0.24
0.22
0.24
0
—
—
—
Long term debt to total equity ratio
0.49
0.46
0.45
0
—
—
—
Per share metrics
Operating cash flow per share
2.58
2.34
1.89
2
3.07
0.84
0.33
EBIT per share
3.24
1.58
0.75
-0.09
1.46
-1.1
-2.28
EBITDA per share
3.57
2.18
2.13
1.43
2.9
0.52
-0.5
Total debt per share
6.81
6.98
6.52
—
—
—
—
Cash per share
7.87
6.25
7.48
4.59
1.24
2.28
3.1
Net current asset value per share
11.74
11.07
11.9
8.88
12.26
11.41
12.46
Tangible book value per share
13.87
15.01
14.37
3.69
18.51
6.51
7.62
Working capital per share
7.18
5.27
0.75
3.66
7.04
5.42
6.48
Book value per share
13.87
15.01
14.37
16.6
18.51
18.81
17.76
News
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
New Strong Buy Stocks for August 7th
Best Value Stocks to Buy for August 7th
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
Stocks Settle Sharply Higher as Middle East Tensions Ease
Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript
Supernus And Indivior Merger: There May Be Some Skepticism, But I Have Faith In This Deal
Stocks Rally on Easing Geopolitical Risks and US Economic Strength